Abstract
Tic, short for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, is a kind of unnatural α-amino acids. Due to its distinct geometrical conformation and biological activity, the structure of Tic, regarded as the surrogate of proline and the rigid analogue of phenylalanine or tyrosine, has been introduced into many compounds, which target diverse enzymes or receptors. The most successful example is that substituting the Tic residue for the proline residue of enalapril led to an approved drug quinapril. In this review, we will summarize the applications and modifications of Tic in peptides and peptidomimetics design and discovery, and hope to spark medicinal researchers inspiration in the field of protein and peptide drug design and optimization.
Keywords: 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic), opioid ligands, farnesyl transferase inhibitors, integrin antagonists, angiotensin-converting enzyme inhibitors, prolyl endopeptidases inhibitors, endogenous mammalian, opiod receptor antagonists, linker, anxiety, depression, schizophrenia, addiction, eating disorders, glycoprotein receptors, immunosupressant
Current Protein & Peptide Science
Title: Applications and Modifications of 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (Tic) in Peptides and Peptidomimetics Design and Discovery
Volume: 11 Issue: 8
Author(s): Yingjie Zhang, Hao Fang and Wenfang Xu
Affiliation:
Keywords: 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic), opioid ligands, farnesyl transferase inhibitors, integrin antagonists, angiotensin-converting enzyme inhibitors, prolyl endopeptidases inhibitors, endogenous mammalian, opiod receptor antagonists, linker, anxiety, depression, schizophrenia, addiction, eating disorders, glycoprotein receptors, immunosupressant
Abstract: Tic, short for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, is a kind of unnatural α-amino acids. Due to its distinct geometrical conformation and biological activity, the structure of Tic, regarded as the surrogate of proline and the rigid analogue of phenylalanine or tyrosine, has been introduced into many compounds, which target diverse enzymes or receptors. The most successful example is that substituting the Tic residue for the proline residue of enalapril led to an approved drug quinapril. In this review, we will summarize the applications and modifications of Tic in peptides and peptidomimetics design and discovery, and hope to spark medicinal researchers inspiration in the field of protein and peptide drug design and optimization.
Export Options
About this article
Cite this article as:
Zhang Yingjie, Fang Hao and Xu Wenfang, Applications and Modifications of 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (Tic) in Peptides and Peptidomimetics Design and Discovery, Current Protein & Peptide Science 2010; 11 (8) . https://dx.doi.org/10.2174/138920310794557691
DOI https://dx.doi.org/10.2174/138920310794557691 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Clinical Application of Ghrelin
Current Pharmaceutical Design Beta-arrestin Biased Agonism/Antagonism at Cardiovascular Seven Transmembrane-spanning Receptors
Current Pharmaceutical Design Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles
Current Pharmaceutical Design Lifestyle Modification for Masked Hypertension
Current Hypertension Reviews Endocannabinoids and their Involvement in the Neurovascular System
Current Neurovascular Research The Role of NPY and Ghrelin in Anorexia Nervosa
Current Pharmaceutical Design Opioids and Mechanical Ventilation
Current Drug Targets Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Functional Signaling Biases in G Protein-Coupled Receptors: Game Theory and Receptor Dynamics
Mini-Reviews in Medicinal Chemistry Cardiovascular Control After Spinal Cord Injury
Current Vascular Pharmacology Herbal Natural Products As a Source of Monoamine Oxidase Inhibitors: A Review
Current Topics in Medicinal Chemistry Some Peculiar Effects of NO-Synthase Inhibition on the Structure and Function of Cardiovascular System
Current Pharmaceutical Biotechnology Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
Current Medicinal Chemistry Upper Airway Resistance Syndrome
Current Respiratory Medicine Reviews TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension
Current Topics in Medicinal Chemistry Potential Beneficial Effects of Garlic in Oncohematology
Mini-Reviews in Medicinal Chemistry Perioperative Considerations in Patients with Obstructive Sleep Apnea
Current Respiratory Medicine Reviews NO Signaling Through cGMP in Renal Tissue Fibrosis and Beyond: Key Pathway and Novel Therapeutic Target
Current Medicinal Chemistry